OVERVIEW

Cardio-Protective Properties of DM Pharmacotherapies: A Case Study is organized by American College of Cardiology (ACC).

Issued Date: April 4, 2018
Term of Approval/Date of CME/MOC/CNE Expiration: April 4, 2021

Target Audience:
This activity is primarily intended for general adult cardiologists and the cardiovascular care team (nurse practitioners, registered nurses, physician assistants and pharmacists). Endocrinologists and primary care physicians may also benefit from this education.

Credit Offered:
• CME:0.25
• CNE:0.25
• COP:0.25
• MOC:0.25

Description:
In this case study, you will apply knowledge of the cardio-protective potential and co-morbidities of DM pharmacotherapy to solve a case-based scenario.

Learner Objectives:
Upon completing this activity, learners should be able to:
• Apply knowledge of the cardio-protective potential and co-morbidities of DM pharmacotherapy to solve a case-based scenario.

Additional details will be posted as soon as they are available.